Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Cochlear ( (AU:COH) ) has shared an update.
Cochlear Limited has announced a change in the interests of its director, Caroline Louise Clarke, involving the acquisition of 418 fully paid ordinary shares through on-market trades. This change reflects a strategic adjustment in the director’s investment in the company, potentially signaling confidence in Cochlear’s market performance and future prospects.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$329.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in the development and manufacture of implantable hearing solutions. The company focuses on providing innovative products to improve hearing for individuals with severe to profound hearing loss, positioning itself as a leader in the auditory implant market.
Average Trading Volume: 179,868
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$19.77B
For detailed information about COH stock, go to TipRanks’ Stock Analysis page.